Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT00634608
First received: February 22, 2008
Last updated: March 1, 2011
Last verified: March 2011
  Purpose

The specific aim of this proposed project is to implement a standard process for integrating MedlinePlus health information prescriptions into the clinic workflow.

Hypothesis 1: Individuals in the intervention group who receive tailored email health information with provider selected MedlinePlus links and added commentary for patient specific conditions will be more likely to seek information / use MedlinePlus compared with individuals in the control group.

Hypothesis 2: Individuals in the intervention group who receive tailored email health information with provider selected MedlinePlus links and added commentary for patient specific conditions will be more satisfied with the information received compared with individuals in the control group.


Condition Intervention
Allergic Rhinitis (Disorder)
Asthma
Back Pain
Benign Prostatic Hypertrophy
Bursitis
Depression
Anxiety
Diabetes Mellitus
Esophageal Reflux
HIV Infections
Hyperlipidemia
Hypertension
Insomnia
Irritable Bowel Syndrome
Obesity
Osteoporosis (Senile)
Shoulder Pain
Sinusitis
Symptomatic Menopause
Urinary Incontinence
Urinary Tract Infection
Vaginitis
Other: Health Information Prescription - MedlinePlus link

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

Resource links provided by NLM:


Further study details as provided by University of Missouri-Columbia:

Primary Outcome Measures:
  • health information experiences of the patient [ Time Frame: approximately one week following clinic appointment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • clinician feedback on the health information prescription process [ Time Frame: midpoint and conclusion of the study ] [ Designated as safety issue: No ]

Estimated Enrollment: 400
Study Start Date: February 2008
Study Completion Date: March 2009
Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1. Control
  1. While patient is waiting in exam room for physician, a research assistant will enter the exam room and speak with the patient.
  2. The research assistant will record the patient's name, willingness to share email, and willingness to participate in the study at the time of the patient encounter. She will later collect their address, gender, age, date of visit, clinic name, and billing diagnoses from IDX data after leaving the exam room.
  3. Physician evaluates the patient and documents the diagnoses for the clinic visit on the billing sheet as per their usual practice. At the end of the clinic session/day, the research assistant will review the billing sheets and record all the listed diagnoses for the control patients.
  4. The research assistant mails the control patients a f/u survey within one week of clinic visit. The surveys will be coded to correspond to diagnosis from billing data.
Experimental: 2. Health Information Prescription
  1. PSR hands the patient the Health Information Prescription (HIP) order form, and patient writes their name at the top of the form. HIP order form will ask if patient uses email, and if they would be willing to share their email address.
  2. Physician evaluates the patient, tells the patient they are ordering a Health Information Prescription, and checks a diagnosis on the HIP form.
  3. Patient returns to PSR to check-out. If patient has an HIP order, PSR refers patient to the research assistant.
  4. The research assistant will record patient name, email address, willingness to participate in the study, and diagnosis at that time, and have patient sign consent and HIPAA authorization. She will later obtain age, date of visit, clinic name, address and diagnoses from billing data from IDX.
  5. The research assistant sends the HIP email within 24 hours of the visit, and mails the survey within 5 business days of clinic visit.
Other: Health Information Prescription - MedlinePlus link
The patient education materials will consist of approximately 21 topics representing some of the most common conditions seen at the Fairview Internal Medicine Clinic. Twenty-one e-mails, one per topic, will be created by Fairview physicians to be distributed to selected clinic patients. There will be a standard e-mail for each condition with a specific link to MedlinePlus. To create the targeted health information topic email, the physician will review the information available at MedlinePlus. The physician will then select several links of appropriate information and, using the template, will write a short annotation on each link.

Detailed Description:

Providing patient education in an outpatient practice can be challenging in part due to the variety of patient medical conditions and the quantity of materials needed. Increasingly, electronic resources such as those found on the internet have the potential to provide easily accessible needed information. However, clinicians do not have the time to assemble a list of websites for their patients and even if they did, the quality of information varies greatly and would require close screening. MedlinePlus is a free National Library of Medicine sponsored website that features health information on hundreds of conditions with all information carefully screened for quality standards by expert librarians. We will conduct a pilot study to seamlessly integrate provider-customized MedlinePlus health education prescriptions for specific conditions into the normal clinic workflow to motivate patients to access and expand their use of MedlinePlus to benefit their health. As HIV prevention/education is very important, we will include the HIV clinic as well as a general internal medicine clinic.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • To be included in the study population, patients must also be seen by their physician for one of the 21 target health conditions (Allergic Rhinitis, Asthma, Back Pain, Benign Prostatic Hypertrophy, Bursitis, Depression/Anxiety, Diabetes Mellitus, Esophageal Reflux, HIV, Hyperlipidemia, Hypertension, Insomnia, Irritable Bowel Syndrome, Obesity, Osteoporosis (senile), Shoulder Pain, Sinusitis, Symptomatic Menopause, Urinary Incontinence, Urinary Tract Infection, Vaginitis) and be willing to provide an email address.
  • Patients will be included only once.
  • All patients in the intervention and the control group will receive the survey.
  • All physicians and staff at the Fairview Clinic and HIV Clinic will be invited to complete the physician or staff survey.

Exclusion Criteria:

  • No email address
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00634608

Locations
United States, Missouri
University of Missouri, Department of Internal Medicine
Columbia, Missouri, United States, 65211
Sponsors and Collaborators
University of Missouri-Columbia
Investigators
Principal Investigator: Robert Hodge, MD University of Missouri-Columbia
  More Information

Publications:
Responsible Party: Robert Hodge, University of Missouri
ClinicalTrials.gov Identifier: NCT00634608     History of Changes
Other Study ID Numbers: HHSN276200700263P
Study First Received: February 22, 2008
Last Updated: March 1, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Anxiety Disorders
Asthma
Back Pain
Prostatic Hyperplasia
Bursitis
Depression
Depressive Disorder
Diabetes Mellitus
Gastroesophageal Reflux
Hyperlipidemias
Hypertension
Hypertrophy
Irritable Bowel Syndrome
Obesity
Osteoporosis
Rhinitis
Shoulder Pain
Sinusitis
Urinary Incontinence
Urinary Tract Infections
Vaginitis
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes

ClinicalTrials.gov processed this record on July 22, 2014